News tagged with drug companies
Treatment leads to near-normal life expectancy for people with HIV in South Africa
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count ...
HIV & AIDS
Apr 09, 2013 |
2 / 5 (1) |
0
Canada loses out on drug pricing, study says
Health systems worldwide are increasingly negotiating secret price rebates from pharmaceutical companies and Canadians risk losing out on the deal.
Health
Apr 08, 2013 |
5 / 5 (1) |
0
India's rejection of drug patent could reverberate
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. ...
Medications
Apr 01, 2013 |
not rated yet |
0
New study explores role of social responsibility in drug development
(Medical Xpress)—Though pharmaceutical companies that are developing "orphan drugs" do so mainly for the business potential, the companies also consider the effort as part of their corporate social responsibility, ...
Medications
Apr 01, 2013 |
not rated yet |
0
High court weighs drug companies' generics policy
(AP)—The Supreme Court is struggling with whether it should stop pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.
Medications
Mar 25, 2013 |
not rated yet |
0
AstraZeneca settles legal dispute with Watson (Update)
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca has settled a patent dispute with Watson Laboratories, Inc., removing a threat against its top-selling cholesterol-control drug, Crestor.
Medications
Mar 25, 2013 |
not rated yet |
0
Malaria vaccine fails to work after four years
A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.
Medications
Mar 20, 2013 |
1 / 5 (1) |
0
US to revise cigarette warning labels (Update)
The U.S. government is abandoning a legal battle to require that cigarette packs carry a set of large and often macabre warning labels depicting the dangers of smoking and encouraging smokers to quit.
Health
Mar 19, 2013 |
4 / 5 (2) |
2
Tobacco industry appears to have evaded FDA ban on 'light' cigarette descriptors
New research from Harvard School of Public Health (HPSH) shows that one year after the federal government passed a law banning word descriptors such as "light," "mild," and "low" on cigarette packages, smokers can still easily ...
Health
Mar 13, 2013 |
5 / 5 (1) |
0
New drug shows promise in ability to fight rare type of breast cancer
Researchers in the University of Delaware's Department of Biological Sciences are investigating a new drug that has shown positive results in early tests of its ability to fight a rare and aggressive form ...
Cancer
Mar 08, 2013 |
5 / 5 (3) |
0
Merck Q4 net profit more than doubles
Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.
Other
Mar 07, 2013 |
2 / 5 (1) |
0
Pharmaceutical companies: An $84 million marketing effort in the District of Columbia
Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according ...
Medications
Mar 01, 2013 |
not rated yet |
0
Deworming important for children's health, has limited impact on infection in wider communities
Although they have an important impact on children's health and education, school-based deworming programmes have a limited impact on the level of infection in the wider community, according to a mathematical modeling study ...
Diseases, Conditions, Syndromes
Feb 28, 2013 |
not rated yet |
0
FDA: Omontys injection pulled from market
(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis ...
Medications
Feb 26, 2013 |
not rated yet |
0
Researchers find new clue to clinical trial failures of MMP cancer therapies
Proposed cancer therapeutic drugs based on blocking the catalytic activities of matrix metalloproteinases (MMPs), which profoundly remodel the environment surrounding a breast cell, have performed poorly ...
Cancer
Feb 12, 2013 |
not rated yet |
0
